p53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors

Aromatase inhibitors have played a central role in endocrine therapy for estrogen receptor (ER)-positive breast cancer in postmenopausal women. However, factors predictive of the efficacy of aromatase inhibitors, and prognostic factors, both for early and late recurrence in women treated with adjuva...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Mitsugu, Hosoda, Mitsuchika, Nakano, Kiichiroh, Jia, Shusheng, Hatanaka, Kanako C, Takakuwa, Emi, Hatanaka, Yutaka, Matsuno, Yoshihiro, Yamashita, Hiroko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317887/
https://www.ncbi.nlm.nih.gov/pubmed/24118529
http://dx.doi.org/10.1111/cas.12302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317887/
https://www.ncbi.nlm.nih.gov/pubmed/24118529
http://dx.doi.org/10.1111/cas.12302

Ejemplares similares